GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (TSX:OGI) » Definitions » Capital Expenditure

OrganiGram Holdings (TSX:OGI) Capital Expenditure : C$-11.53 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is OrganiGram Holdings Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

OrganiGram Holdings's cash flow for capital expenditures for the three months ended in Mar. 2024 was C$-0.9 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was C$-11.53 Mil.

OrganiGram Holdings Capital Expenditure Historical Data

The historical data trend for OrganiGram Holdings's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings Capital Expenditure Chart

OrganiGram Holdings Annual Data
Trend Apr12 Apr13 Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.17 -56.44 -110.29 -78.65 -12.30

OrganiGram Holdings Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.38 -5.57 -9.14 -1.53 -0.86

OrganiGram Holdings Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrganiGram Holdings (TSX:OGI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (TSX:OGI) » Definitions » Capital Expenditure
Comparable Companies
XCNQ:AYR.A XCNQ:JUSH TSX:CPH TSXV:RX TSXV:LOVE XCNQ:INNO TSX:CRDL XCNQ:GRIN TSX:HLS TSXV:ZYUS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
OGI:USA 0OG0:Germany
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Website
https://www.organigram.ca
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
Executives
Donald Geoffrey Machum Director